Toll-like receptors and NOD-like receptors in rheumatic diseases

71Citations
Citations of this article
103Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The past 10 years have seen the description of families of receptors that drive proinflammatory cytokine production in infection and tissue injury. Two major classes have been examined in the context of inflammatory joint disease - the Toll-like receptors (TLRs) and NOD-like receptors (NLRs). TLRs such as TLR2 and TLR4 are being implicated in the pathology of rheumatoid arthritis, ankylosing spondylitis, lyme arthritis and osteoarthritis. Nalp3 has been identified as a key NLR for IL-1β production and has been shown to have a particular role in gout. These findings present new therapeutic opportunities, possibly allowing for the replacement of biologics with small molecule inhibitors. © 2009 BioMed Central Ltd.

Cite

CITATION STYLE

APA

McCormack, W. J., Parker, A. E., & O’Neill, L. A. (2009, October 14). Toll-like receptors and NOD-like receptors in rheumatic diseases. Arthritis Research and Therapy. https://doi.org/10.1186/ar2729

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free